

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | The cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway mediates anti-microbial innate immunity by inducing the production of type I interferons (IFNs) and inflammatory cytokines upon recognition of microbial DNA. Recent studies reveal that self-DNA from tumors and by-products of genomic instability also activates the cGAS-STING pathway and either promotes or inhibits tumor development[1]. On the one hand, the cGAS-STING axis promotes the clearance of CIN tumors through recruitment of immune cells, thus suppressing tumor progression. On the other hand, the cGAS-STING pathway has been described to be the major regulator in the promotion of metastasis of Chromosomal instability (CIN) tumors[2]. In renal cells of TFAM KO (knockout) mice, aberrant packaging of the mitochondrial DNA (mtDNA) resulted in its cytosolic translocation, activation of the cytosolic cGAS-stimulator of interferon genes (STING) DNA sensing pathway, and thus cytokine expression and immune cell recruitment[3]. SN-011 locks STING in an open inactive conformation, which inhibits interferon and inflammatory cytokine induction activated by 2'3'-cGAMP, herpes simplex virus type 1 infection, Trex1 deficiency, overexpression of cGAS-STING, or SAVI STING mutants. In Trex1 -/- mice, SN-011 was well tolerated, strongly inhibited hallmarks of inflammation and autoimmunity disease, and prevented death. Thus, a specific STING inhibitor that binds to the STING CDN-binding pocket is a promising lead compound for STING-driven disease[4]. |
| Concentration | Treated Time | Description | References | |
| Human foreskin fibroblasts (HFFs) | 1 µM | 6 hours | Inhibited 2'3'-cGAMP-induced IFNB mRNA expression | Proc Natl Acad Sci U S A. 2021 Jun 15;118(24):e2105465118 |
| Human monocyte cell line THP-1 | 1 µM | 6 hours | Inhibited HSV-1 infection-induced Ifnb mRNA expression | Proc Natl Acad Sci U S A. 2021 Jun 15;118(24):e2105465118 |
| L929 mouse fibroblasts | 1 µM | 6 hours | Inhibited HT-DNA-induced Ifnb mRNA expression | Proc Natl Acad Sci U S A. 2021 Jun 15;118(24):e2105465118 |
| Mouse embryonic fibroblasts (MEFs) | 1 µM | 6 hours | Inhibited STING-triggered Ifnb gene induction | Proc Natl Acad Sci U S A. 2021 Jun 15;118(24):e2105465118 |
| Administration | Dosage | Frequency | Description | References | ||
| C57BL/6 mice | Periodontitis mouse model | Intraperitoneal injection | 10 mg/kg | Daily dosing for 7 days | To evaluate the effect of SN-011 on inflammatory response and bone resorption in a periodontitis mouse model. Results showed that SN-011 significantly decreased inflammatory cytokine production and osteoclast formation. | Front Microbiol. 2023 Jun 19;14:1183415 |
| Mice | Trex1−/− mouse model | Intraperitoneal injection | 5 mg/kg | Three times per week for one month | Inhibited systemic inflammation and autoimmune markers, prevented death | Proc Natl Acad Sci U S A. 2021 Jun 15;118(24):e2105465118 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.16mL 0.43mL 0.22mL |
10.81mL 2.16mL 1.08mL |
21.62mL 4.32mL 2.16mL |
|
| CAS号 | 2249435-90-1 |
| 分子式 | C25H19FN2O4S |
| 分子量 | 462.49 |
| SMILES Code | O=C(C1=CC=C(C2=CC=CC=C2)C=C1)NC3=CC=C(O)C(NS(=O)(C4=CC=C(F)C=C4)=O)=C3 |
| MDL No. | N/A |
| 别名 | GUN35901 |
| 运输 | 蓝冰 |
| InChI Key | GPXQUPCJIJBXHJ-UHFFFAOYSA-N |
| Pubchem ID | 138005721 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry,2-8°C |
| 溶解方案 |
DMSO: 105 mg/mL(227.03 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1